Resistance modifying agents are active in some patients with hematological malignancy

Effect of Cytotoxic Cells on Minimal Residual Leukemia.

Leukemia & lymphoma·2016

Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty.

Obesity surgery·2000

Blocking of MHC class I antigens on leukemic B-cells enhances their conjugate formation with cytotoxic lymphocytes and their susceptibility to lysis.

Leukemia & lymphoma·1998

Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesis.

Leukemia research·1994

The quandary of cancer prevention.

Journal of clinical epidemiology·1994

Conjugate formation by leukemic blasts from acute myeloid leukemia with cytotoxic lymphocytes.

Leukemia & lymphoma·1993

Bioluminescent xenograft model of acute myeloid leukemia for immunotherapy preclinical studies.

Leukemia research·2026

Multispecialty referral patterns to a clonal hematopoiesis clinic: Who, what, and why?

Leukemia research·2026

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026

Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.

Przeglad menopauzalny = Menopause review·2026

BCR-ABL1 Transcript Variants in Chronic Myeloid Leukemia Patients in Africa: A Systematic Review.

Health science reports·2026

Classical Hodgkin Lymphoma Today.

Mediterranean journal of hematology and infectious diseases·2026

Jiedu Xiaoliu formula enhances progression-free survival and immune modulation in diffuse large B-cell lymphoma: a retrospective cohort study.

Frontiers in pharmacology·2026

LTF promotes central nervous system leukemia progression via neutrophil serine proteases.

Frontiers in pharmacology·2026

Case Report: refractory hemophagocytic lymphohistiocytosis progression despite complete metabolic response in a patient with stage IV extranodal NK/T-cell lymphoma: clinical observation of "tumor-immune dissociation" phenomenon.

Frontiers in immunology·2026

Related Experiment Videos

Resistance modifying agents are active in some patients with hematological malignancy

Related Concept Videos

Effect of Cytotoxic Cells on Minimal Residual Leukemia.

Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty.

Blocking of MHC class I antigens on leukemic B-cells enhances their conjugate formation with cytotoxic lymphocytes and their susceptibility to lysis.

Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesis.

The quandary of cancer prevention.

Conjugate formation by leukemic blasts from acute myeloid leukemia with cytotoxic lymphocytes.

Bioluminescent xenograft model of acute myeloid leukemia for immunotherapy preclinical studies.

Multispecialty referral patterns to a clonal hematopoiesis clinic: Who, what, and why?

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.

BCR-ABL1 Transcript Variants in Chronic Myeloid Leukemia Patients in Africa: A Systematic Review.

Classical Hodgkin Lymphoma Today.

Jiedu Xiaoliu formula enhances progression-free survival and immune modulation in diffuse large B-cell lymphoma: a retrospective cohort study.

LTF promotes central nervous system leukemia progression via neutrophil serine proteases.

Case Report: refractory hemophagocytic lymphohistiocytosis progression despite complete metabolic response in a patient with stage IV extranodal NK/T-cell lymphoma: clinical observation of "tumor-immune dissociation" phenomenon.

Related Experiment Videos

Resistance modifying agents are active in some patients with hematological malignancy

Related Concept Videos

Related Articles